Time resolved quantitative phosphoproteomics reveals distinct patterns of SHP2 dependence in EGFR signaling
2019
SHP2 is a
protein tyrosine phosphatasethat normally potentiates intracellular signaling by growth factors, antigen receptors, and some cytokines; it is frequently mutated in
childhood leukemiasand other cancers. Here, we examine the role of SHP2 in the responses of breast cancer cells to EGF by monitoring
phosphoproteomedynamics when SHP2 is allosterically inhibited by the small molecule SHP099. Data on phosphotyrosine abundance at more than 400 tyrosine residues reveals six distinct response signatures following SHP099 treatment and
washout. These include putative substrate sites with increased phosphotyrosine abundance at early or late timepoints, and another class of sites that shows reduced phosphotyrosine abundance when SHP099 is present. Sites of decreased phosphoabundance are enriched on proteins with two nearby phosphotyrosine residues, which can be directly protected from dephosphorylation by the paired
SH2 domainsof SHP2 itself. These findings highlight how analysis of
phosphoproteomicdynamics can provide insight into transmembrane signaling responses.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
40
References
3
Citations
NaN
KQI